Company intelligence / Profile preview

ViaGen

Austin, Texas, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Successfully cloned 15 animal species (including endangered and domestic species), maintains >80% cloning efficiency in several species, provides global services in animal genetic preservation and advanced reproductive technologies[1].

Therapeutic areas: OtherWomen's Health
Modalities: Cell therapyCryopreservationSomatic cell nuclear transfer (SCNT)Intracytoplasmic sperm injection (ICSI)
Industry: Veterinary

Partnerships

San Diego Zoo (endangered species genetics biobanking and cloning)[1][4]U.S. Fish and Wildlife (species restoration)[4]ST Genetics (exclusive license for Sexed Semen Technology, US/Canada)[1]

Beyond the preview

Go deeper on ViaGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViaGen.

Explore the full profile